Safety and Preliminary Efficacy of GLPG0634 in Methotrexate-refractory Active Rheumatoid Arthritis Patients.
Phase of Trial: Phase II
Latest Information Update: 16 Jun 2017
At a glance
- Drugs Filgotinib (Primary) ; Methotrexate
- Indications Rheumatoid arthritis
- Focus Proof of concept; Therapeutic Use
- Sponsors Galapagos NV
- 10 Jun 2017 Biomarkers information updated
- 13 Jun 2015 Results assessing gene signature presented at the 16th Annual Congress of the European League Against Rheumatism.
- 30 Oct 2013 Results assessing pharmacodynamic parameters and metabolite pharmacokinetics presented at the 77th American College of Rheumatology and the 48th Annual Meeting of the Association of Rheumatology and Health Professionals.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History